NEW! Earn 13.25 CEs: SBIA | Generic Drugs Forum 2024: Regulatory Considerations to Enhance Generic Drug Access

Receive this email as a forward? Subscribe to CDER SBIA industry updates.

CDER SBIA Webinar Registration

CDER Small Business and Industry Assistance (SBIA)

presents

Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access

Bookmark and Share


Join us in person or online

No Fee Registration

Agenda

Test your knowledge: Take the LinkedIn poll

Day One:  -  ET

Day Two:  -  ET


Generic Drug Forum 2024 video thumbnail with a play button in the center

🔹 ABOUT THIS EVENT 

The Generic Drugs Forum is an annual, two-day event that offers attendees the opportunity to hear from FDA subject matter experts from every part of the pre-ANDA program and ANDA assessment program. The goal of the forum is to provide practical regulatory information to aid prospective applicants in submitting complete and high-quality applications to maximize the efficiency and utility of each assessment cycle, with the intent to reduce the number of assessment cycles and facilitate timely access to safe, effective, and high-quality generic medicines.

This year’s theme is Regulatory Considerations to Enhance Generic Drug Access, and our agenda will address essential regulatory information on how to engage with the Agency and gain information about ANDA development and ANDA assessment. 

🔹 TOPICS COVERED

  • Controlled Correspondence
  • Pre-ANDA Submissions and Meetings
  • ANDA Submissions, Assessments, and Meetings
  • Post-Approval Submissions

 

Read More

🔹 INTENDED AUDIENCE

The generic drug industry, consultants, regulatory affairs professionals, or contractors with an emphasis on those who:

  • Are involved in generic drug development
  • Are submitting or have submitted a generic drug application, amendment, or supplement